Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feiyang Liu

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Environmental Science & Technology|May 15, 2026
A Comprehensive Analytical Procedure and Environmental Behavior of Lithium-Ion Battery-Related Fluorinated Anions and Ultrashort-Chain PFASZhuofan Shi, Feiyue Zhu, Feiyang Liu, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|July 13, 2026
[Effect of <i>Tongdu Tiaoshen</i> acupuncture on neuroinflammation in rats with CUMS based on the miR-26a-5p/EZH2/H3K27me3 pathway]Wen Pan, Daozong Zhang, Shiyi Jiao, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 10, 2026
Unified Interface-Bulk Enhancements in Wide-Bandgap Perovskites Enabled by Bifunctional Cyanoacetic Acid for Textured Silicon/Perovskite Tandem Solar CellsShaojie Yuan, Fengchun Cai, Zhengjie Zhu, et al.
NPJ Parkinson'S Disease|January 8, 2025
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson's disease model triggered by α-synuclein overexpressionZhen Zhang, Kun Niu, Taoying Huang, et al.
European Journal of Medicinal Chemistry|October 12, 2023
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou, et al.
Cancer Research|July 30, 2017
Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung AdenocarcinomaYan Liu, Yuyang Li, Xiaoen Wang, et al.
Signal Transduction and Targeted Therapy|January 15, 2023
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Hong Wu, Jing Yang, et al.
Leukemia|May 6, 2014
Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignanciesEllen Weisberg, Atsushi Nonami, Zhao Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2014
Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1REllen Weisberg, Atsushi Nonami, Zhao Chen, et al.
Molecular Oncology|February 23, 2022
Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumoursJuan Liu, Jingjing Gao, Aoli Wang, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Environmental Science & Technology|May 15, 2026
A Comprehensive Analytical Procedure and Environmental Behavior of Lithium-Ion Battery-Related Fluorinated Anions and Ultrashort-Chain PFASZhuofan Shi, Feiyue Zhu, Feiyang Liu, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|July 13, 2026
[Effect of <i>Tongdu Tiaoshen</i> acupuncture on neuroinflammation in rats with CUMS based on the miR-26a-5p/EZH2/H3K27me3 pathway]Wen Pan, Daozong Zhang, Shiyi Jiao, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 10, 2026
Unified Interface-Bulk Enhancements in Wide-Bandgap Perovskites Enabled by Bifunctional Cyanoacetic Acid for Textured Silicon/Perovskite Tandem Solar CellsShaojie Yuan, Fengchun Cai, Zhengjie Zhu, et al.
NPJ Parkinson'S Disease|January 8, 2025
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson's disease model triggered by α-synuclein overexpressionZhen Zhang, Kun Niu, Taoying Huang, et al.
European Journal of Medicinal Chemistry|October 12, 2023
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou, et al.
Cancer Research|July 30, 2017
Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung AdenocarcinomaYan Liu, Yuyang Li, Xiaoen Wang, et al.
Signal Transduction and Targeted Therapy|January 15, 2023
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Hong Wu, Jing Yang, et al.
Leukemia|May 6, 2014
Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignanciesEllen Weisberg, Atsushi Nonami, Zhao Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2014
Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1REllen Weisberg, Atsushi Nonami, Zhao Chen, et al.
Molecular Oncology|February 23, 2022
Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumoursJuan Liu, Jingjing Gao, Aoli Wang, et al.
Pageof 9